| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 586 | 560 | 591 | 642 | 682 | 708 | 620 | 720 | 754 | 856 | 841 | 940 | |
Growth YoY Revenue Growth YoY% | 22.1 | 15.2 | 18.1 | 20.8 | 16.3 | 26.5 | 5.0 | 12.2 | 10.6 | 20.8 | 35.6 | 30.5 |
| 453 | 450 | 462 | 495 | 543 | 582 | 520 | 576 | 594 | 661 | 628 | 726 | |
| 133 | 110 | 128 | 147 | 139 | 127 | 100 | 145 | 161 | 195 | 213 | 214 | |
OPM OPM% | 22.7 | 19.6 | 21.7 | 22.9 | 20.4 | 17.9 | 16.1 | 20.1 | 21.3 | 22.8 | 25.3 | 22.8 |
| 5 | 17 | 15 | 0 | 28 | 15 | 6 | 22 | 20 | 35 | 25 | 18 | |
Interest Expense Interest ExpenseCr | 3 | 5 | 3 | 3 | 3 | 3 | 6 | 6 | 6 | 6 | 7 | 7 |
Depreciation DepreciationCr | 22 | 21 | 20 | 20 | 21 | 23 | 23 | 27 | 24 | 24 | 25 | 32 |
PBT PBTCr | 113 | 100 | 120 | 125 | 143 | 116 | 77 | 133 | 151 | 200 | 207 | 194 |
| 30 | 23 | 31 | 27 | 38 | 25 | 18 | 34 | 37 | 51 | 47 | 50 | |
| 83 | 78 | 89 | 98 | 105 | 91 | 58 | 99 | 114 | 149 | 159 | 144 | |
Growth YoY PAT Growth YoY% | 33.2 | -6.1 | 26.4 | 16.6 | 26.6 | 16.9 | -34.7 | 1.4 | 8.2 | 64.3 | 173.9 | 44.8 |
NPM NPM% | 14.2 | 13.9 | 15.1 | 15.2 | 15.4 | 12.8 | 9.4 | 13.8 | 15.1 | 17.4 | 19.0 | 15.3 |
| 1.8 | 1.7 | 2.0 | 2.1 | 2.3 | 2.0 | 1.3 | 2.2 | 2.5 | 3.3 | 3.5 | 3.1 |
| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 586 | 560 | 591 | 642 | 682 | 708 | 620 | 720 | 754 | 856 | 841 | 940 | |
Growth YoY Revenue Growth YoY% | 22.1 | 15.2 | 18.1 | 20.8 | 16.3 | 26.5 | 5.0 | 12.2 | 10.6 | 20.8 | 35.6 | 30.5 |
| 453 | 450 | 462 | 495 | 543 | 582 | 520 | 576 | 594 | 661 | 628 | 726 | |
| 133 | 110 | 128 | 147 | 139 | 127 | 100 | 145 | 161 | 195 | 213 | 214 | |
OPM OPM% | 22.7 | 19.6 | 21.7 | 22.9 | 20.4 | 17.9 | 16.1 | 20.1 | 21.3 | 22.8 | 25.3 | 22.8 |
| 5 | 17 | 15 | 0 | 28 | 15 | 6 | 22 | 20 | 35 | 25 | 18 | |
Interest Expense Interest ExpenseCr | 3 | 5 | 3 | 3 | 3 | 3 | 6 | 6 | 6 | 6 | 7 | 7 |
Depreciation DepreciationCr | 22 | 21 | 20 | 20 | 21 | 23 | 23 | 27 | 24 | 24 | 25 | 32 |
PBT PBTCr | 113 | 100 | 120 | 125 | 143 | 116 | 77 | 133 | 151 | 200 | 207 | 194 |
| 30 | 23 | 31 | 27 | 38 | 25 | 18 | 34 | 37 | 51 | 47 | 50 | |
| 83 | 78 | 89 | 98 | 105 | 91 | 58 | 99 | 114 | 149 | 159 | 144 | |
Growth YoY PAT Growth YoY% | 33.2 | -6.1 | 26.4 | 16.6 | 26.6 | 16.9 | -34.7 | 1.4 | 8.2 | 64.3 | 173.9 | 44.8 |
NPM NPM% | 14.2 | 13.9 | 15.1 | 15.2 | 15.4 | 12.8 | 9.4 | 13.8 | 15.1 | 17.4 | 19.0 | 15.3 |
| 1.8 | 1.7 | 2.0 | 2.1 | 2.3 | 2.0 | 1.3 | 2.2 | 2.5 | 3.3 | 3.5 | 3.1 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 893 | 767 | 913 | 1,000 | 1,134 | 1,376 | 1,491 | 1,852 | 2,177 | 2,623 | 2,951 | 3,392 |
Growth Revenue Growth% | 12.1 | -14.1 | 19.0 | 9.6 | 13.4 | 21.3 | 8.3 | 24.2 | 17.6 | 20.5 | 12.5 | 24.2 |
| 757 | 722 | 834 | 868 | 942 | 1,037 | 1,232 | 1,513 | 1,719 | 2,090 | 2,350 | 2,608 | |
| 136 | 45 | 78 | 132 | 192 | 340 | 259 | 339 | 459 | 533 | 601 | 783 | |
OPM OPM% | 15.3 | 5.8 | 8.6 | 13.2 | 16.9 | 24.7 | 17.4 | 18.3 | 21.1 | 20.3 | 20.4 | 23.1 |
| 9 | 7 | 8 | 5 | 0 | 7 | 42 | 59 | 50 | 66 | 83 | 99 | |
Interest Expense Interest ExpenseCr | 10 | 7 | 10 | 10 | 9 | 8 | 8 | 9 | 11 | 12 | 24 | 26 |
Depreciation DepreciationCr | 28 | 30 | 27 | 23 | 27 | 36 | 45 | 52 | 74 | 83 | 99 | 106 |
PBT PBTCr | 107 | 15 | 50 | 104 | 157 | 302 | 248 | 338 | 424 | 504 | 561 | 751 |
| 24 | 4 | 14 | 24 | 36 | 64 | 61 | 72 | 109 | 121 | 140 | 185 | |
PAT PATCr | 83 | 11 | 36 | 80 | 121 | 239 | 187 | 265 | 315 | 383 | 420 | 566 |
Growth PAT Growth% | -26.1 | -86.3 | 215.9 | 124.7 | 50.1 | 97.5 | -21.7 | 42.0 | 18.7 | 21.5 | 9.8 | 60.2 |
NPM NPM% | 9.3 | 1.5 | 3.9 | 8.0 | 10.7 | 17.3 | 12.5 | 14.3 | 14.5 | 14.6 | 14.2 | 16.7 |
| 1.9 | 0.2 | 0.8 | 1.9 | 2.9 | 5.8 | 4.5 | 6.4 | 6.9 | 8.4 | 9.2 | 12.4 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 893 | 767 | 913 | 1,000 | 1,134 | 1,376 | 1,491 | 1,852 | 2,177 | 2,623 | 2,951 | 3,392 |
Growth Revenue Growth% | 12.1 | -14.1 | 19.0 | 9.6 | 13.4 | 21.3 | 8.3 | 24.2 | 17.6 | 20.5 | 12.5 | 24.2 |
| 757 | 722 | 834 | 868 | 942 | 1,037 | 1,232 | 1,513 | 1,719 | 2,090 | 2,350 | 2,608 | |
| 136 | 45 | 78 | 132 | 192 | 340 | 259 | 339 | 459 | 533 | 601 | 783 | |
OPM OPM% | 15.3 | 5.8 | 8.6 | 13.2 | 16.9 | 24.7 | 17.4 | 18.3 | 21.1 | 20.3 | 20.4 | 23.1 |
| 9 | 7 | 8 | 5 | 0 | 7 | 42 | 59 | 50 | 66 | 83 | 99 | |
Interest Expense Interest ExpenseCr | 10 | 7 | 10 | 10 | 9 | 8 | 8 | 9 | 11 | 12 | 24 | 26 |
Depreciation DepreciationCr | 28 | 30 | 27 | 23 | 27 | 36 | 45 | 52 | 74 | 83 | 99 | 106 |
PBT PBTCr | 107 | 15 | 50 | 104 | 157 | 302 | 248 | 338 | 424 | 504 | 561 | 751 |
| 24 | 4 | 14 | 24 | 36 | 64 | 61 | 72 | 109 | 121 | 140 | 185 | |
PAT PATCr | 83 | 11 | 36 | 80 | 121 | 239 | 187 | 265 | 315 | 383 | 420 | 566 |
Growth PAT Growth% | -26.1 | -86.3 | 215.9 | 124.7 | 50.1 | 97.5 | -21.7 | 42.0 | 18.7 | 21.5 | 9.8 | 60.2 |
NPM NPM% | 9.3 | 1.5 | 3.9 | 8.0 | 10.7 | 17.3 | 12.5 | 14.3 | 14.5 | 14.6 | 14.2 | 16.7 |
| 1.9 | 0.2 | 0.8 | 1.9 | 2.9 | 5.8 | 4.5 | 6.4 | 6.9 | 8.4 | 9.2 | 12.4 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 41 | 41 | 41 | 41 | 41 | 41 | 41 | 45 | 45 | 45 | 45 | 45 |
Reserves ReservesCr | 401 | 393 | 430 | 502 | 595 | 846 | 1,068 | 1,700 | 2,020 | 2,422 | 2,978 | 3,287 |
| 259 | 296 | 235 | 233 | 229 | 299 | 356 | 341 | 390 | 477 | 527 | 600 | |
| 0 | 16 | 17 | 18 | 25 | 25 | 61 | 84 | 205 | 273 | 281 | 392 | |
| 722 | 752 | 732 | 804 | 903 | 1,229 | 1,640 | 2,190 | 2,681 | 3,240 | 3,861 | 4,360 | |
| 440 | 484 | 451 | 531 | 594 | 903 | 1,201 | 1,675 | 1,862 | 2,204 | 2,723 | 3,012 | |
| 282 | 268 | 282 | 272 | 309 | 326 | 439 | 515 | 818 | 1,036 | 1,138 | 1,347 | |
| 722 | 752 | 732 | 804 | 903 | 1,229 | 1,640 | 2,190 | 2,681 | 3,240 | 3,861 | 4,360 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 41 | 41 | 41 | 41 | 41 | 41 | 41 | 45 | 45 | 45 | 45 | 45 |
Reserves ReservesCr | 401 | 393 | 430 | 502 | 595 | 846 | 1,068 | 1,700 | 2,020 | 2,422 | 2,978 | 3,287 |
| 259 | 296 | 235 | 233 | 229 | 299 | 356 | 341 | 390 | 477 | 527 | 600 | |
| 0 | 16 | 17 | 18 | 25 | 25 | 61 | 84 | 205 | 273 | 281 | 392 | |
| 722 | 752 | 732 | 804 | 903 | 1,229 | 1,640 | 2,190 | 2,681 | 3,240 | 3,861 | 4,360 | |
| 440 | 484 | 451 | 531 | 594 | 903 | 1,201 | 1,675 | 1,862 | 2,204 | 2,723 | 3,012 | |
| 282 | 268 | 282 | 272 | 309 | 326 | 439 | 515 | 818 | 1,036 | 1,138 | 1,347 | |
| 722 | 752 | 732 | 804 | 903 | 1,229 | 1,640 | 2,190 | 2,681 | 3,240 | 3,861 | 4,360 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 | 14 | 50 | 27 | 233 | 179 | 99 | 237 | 230 | 207 | 458 | |
| -123 | -21 | -39 | -13 | -60 | -45 | -84 | -259 | -141 | -49 | -248 | |
| -58 | -3 | 3 | -21 | -114 | -15 | 80 | 198 | -69 | -65 | -71 | |
Net Cash Flow Net Cash FlowCr | -150 | -10 | 15 | -7 | 60 | 118 | 94 | 176 | 21 | 93 | 139 |
Free Cash Flow Free Cash FlowCr | -101 | -14 | 11 | 14 | 174 | 133 | 53 | 184 | 22 | 35 | 329 |
CFO To PAT CFO To PAT% | 37.2 | 124.1 | 139.9 | 34.1 | 193.2 | 74.9 | 53.1 | 89.5 | 73.2 | 54.0 | 109.1 |
CFO To EBITDA CFO To EBITDA% | 22.6 | 31.4 | 63.9 | 20.7 | 121.4 | 52.6 | 38.3 | 70.0 | 50.2 | 38.8 | 76.3 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 | 14 | 50 | 27 | 233 | 179 | 99 | 237 | 230 | 207 | 458 | |
| -123 | -21 | -39 | -13 | -60 | -45 | -84 | -259 | -141 | -49 | -248 | |
| -58 | -3 | 3 | -21 | -114 | -15 | 80 | 198 | -69 | -65 | -71 | |
Net Cash Flow Net Cash FlowCr | -150 | -10 | 15 | -7 | 60 | 118 | 94 | 176 | 21 | 93 | 139 |
Free Cash Flow Free Cash FlowCr | -101 | -14 | 11 | 14 | 174 | 133 | 53 | 184 | 22 | 35 | 329 |
CFO To PAT CFO To PAT% | 37.2 | 124.1 | 139.9 | 34.1 | 193.2 | 74.9 | 53.1 | 89.5 | 73.2 | 54.0 | 109.1 |
CFO To EBITDA CFO To EBITDA% | 22.6 | 31.4 | 63.9 | 20.7 | 121.4 | 52.6 | 38.3 | 70.0 | 50.2 | 38.8 | 76.3 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 1,891 | 1,930 | 1,295 | 1,017 | 569 | 2,045 | 1,864 | 3,194 | 6,868 | 10,076 | 7,121 | 13,196 |
Price To Earnings Price To Earnings | 24.4 | 214.3 | 39.6 | 13.3 | 4.7 | 8.7 | 10.1 | 12.0 | 21.9 | 26.5 | 17.0 | 23.6 |
Price To Sales Price To Sales | 2.1 | 2.5 | 1.4 | 1.0 | 0.5 | 1.5 | 1.3 | 1.7 | 3.1 | 3.8 | 2.4 | 3.9 |
Price To Book Price To Book | 4.3 | 4.5 | 2.8 | 1.9 | 0.9 | 2.3 | 1.7 | 1.8 | 3.3 | 4.1 | 2.4 | 4.0 |
EV To EBITDA EV To EBITDA | 14.3 | 45.0 | 17.5 | 8.2 | 2.6 | 5.5 | 6.3 | 7.7 | 14.0 | 18.2 | 10.8 | 16.1 |
GPM GPM% | 37.2 | 34.1 | 36.8 | 43.9 | 45.9 | 53.1 | 49.8 | 47.9 | 46.6 | 49.5 | 49.6 | 49.6 |
OPM OPM% | 15.3 | 5.8 | 8.6 | 13.2 | 16.9 | 24.7 | 17.4 | 18.3 | 21.1 | 20.3 | 20.4 | 23.1 |
NPM NPM% | 9.3 | 1.5 | 3.9 | 8.0 | 10.7 | 17.3 | 12.5 | 14.3 | 14.5 | 14.6 | 14.2 | 16.7 |
ROCE ROCE% | 22.1 | 4.0 | 10.2 | 17.7 | 24.9 | 33.7 | 21.0 | 18.6 | 18.8 | 18.5 | 17.4 | 23.1 |
ROE ROE% | 18.7 | 2.6 | 7.6 | 14.8 | 19.0 | 26.9 | 16.8 | 15.2 | 15.3 | 15.5 | 13.9 | 17.0 |
ROA ROA% | 11.5 | 1.5 | 4.9 | 10.0 | 13.4 | 19.4 | 11.4 | 12.1 | 11.8 | 11.8 | 10.9 | 13.0 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 1,891 | 1,930 | 1,295 | 1,017 | 569 | 2,045 | 1,864 | 3,194 | 6,868 | 10,076 | 7,121 | 13,196 |
Price To Earnings Price To Earnings | 24.4 | 214.3 | 39.6 | 13.3 | 4.7 | 8.7 | 10.1 | 12.0 | 21.9 | 26.5 | 17.0 | 23.6 |
Price To Sales Price To Sales | 2.1 | 2.5 | 1.4 | 1.0 | 0.5 | 1.5 | 1.3 | 1.7 | 3.1 | 3.8 | 2.4 | 3.9 |
Price To Book Price To Book | 4.3 | 4.5 | 2.8 | 1.9 | 0.9 | 2.3 | 1.7 | 1.8 | 3.3 | 4.1 | 2.4 | 4.0 |
EV To EBITDA EV To EBITDA | 14.3 | 45.0 | 17.5 | 8.2 | 2.6 | 5.5 | 6.3 | 7.7 | 14.0 | 18.2 | 10.8 | 16.1 |
GPM GPM% | 37.2 | 34.1 | 36.8 | 43.9 | 45.9 | 53.1 | 49.8 | 47.9 | 46.6 | 49.5 | 49.6 | 49.6 |
OPM OPM% | 15.3 | 5.8 | 8.6 | 13.2 | 16.9 | 24.7 | 17.4 | 18.3 | 21.1 | 20.3 | 20.4 | 23.1 |
NPM NPM% | 9.3 | 1.5 | 3.9 | 8.0 | 10.7 | 17.3 | 12.5 | 14.3 | 14.5 | 14.6 | 14.2 | 16.7 |
ROCE ROCE% | 22.1 | 4.0 | 10.2 | 17.7 | 24.9 | 33.7 | 21.0 | 18.6 | 18.8 | 18.5 | 17.4 | 23.1 |
ROE ROE% | 18.7 | 2.6 | 7.6 | 14.8 | 19.0 | 26.9 | 16.8 | 15.2 | 15.3 | 15.5 | 13.9 | 17.0 |
ROA ROA% | 11.5 | 1.5 | 4.9 | 10.0 | 13.4 | 19.4 | 11.4 | 12.1 | 11.8 | 11.8 | 10.9 | 13.0 |
| Market CapitalizationMkt CapCr | 15,424 | 14,894 | 13,842 | 13,196 | 10,958 | 8,917 | 7,612 |
| Close PriceClose₹ | 2,029.10 | 935.05 | 2,263.20 | 291.15 | 696.20 | 967.30 | 269.40 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 22.38 | 56.29 | 66.86 | 23.56 | 29.30 | 14.46 | |
| Price To SalesPS | 6.47 | 1.65 | 8.88 | 3.89 | 2.27 | 1.71 | 836.51 |
| RevenueRevenueCr | 2,383 | 9,012 | 1,559 | 3,392 | 4,826 | 5,213 | 9 |
| Revenue Growth TTMRev Gr TTM% | 16.8% | 18.3% | 20.0% | 24.2% | 17.5% | 11.3% | 55.0% |
| PAT Growth TTMPAT Gr TTM% | 17.4% | -44.7% | 18.3% | 60.2% | 12.8% | 54.3% | -80.3% |
| Market CapitalizationMkt CapCr | 15,424 | 14,894 | 13,842 | 13,196 | 10,958 | 8,917 | 7,612 |
| Close PriceClose₹ | 2,029.10 | 935.05 | 2,263.20 | 291.15 | 696.20 | 967.30 | 269.40 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 22.38 | 56.29 | 66.86 | 23.56 | 29.30 | 14.46 | |
| Price To SalesPS | 6.47 | 1.65 | 8.88 | 3.89 | 2.27 | 1.71 | 836.51 |
| RevenueRevenueCr | 2,383 | 9,012 | 1,559 | 3,392 | 4,826 | 5,213 | 9 |
| Revenue Growth TTMRev Gr TTM% | 16.8% | 18.3% | 20.0% | 24.2% | 17.5% | 11.3% | 55.0% |
| PAT Growth TTMPAT Gr TTM% | 17.4% | -44.7% | 18.3% | 60.2% | 12.8% | 54.3% | -80.3% |